https://www.indianpharmapost.com/dr-reddys-laboratories-q1-fy2024-consolidated-pat-jumps-to-rs-14025-cr-144432023-07-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/astec-lifesciences-posts-consolidated-q1fy24-loss-at-rs-819-cr-144442023-07-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/laurus-labs-posts-decline-in-q1fy24-consolidated-pat-to-rs-2485-cr-144452023-07-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/dr-lal-path-labs-q1fy24-consolidated-pat-up-at-rs-826-cr-144462023-07-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/ajanta-pharmas-q1-fy24-consolidated-pat-up-at-rs-20812-cr-144472023-07-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/biocon-foundation-releases-2nd-edition-of-consensus-guidelines-for-head-neck-cancer-144482023-07-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/genworks-introduces-mechanical-hysteroscopic-tissue-removal-system-144492023-07-28T00:00:00+05:30always0.9